Ameliora Wealth Management Ltd. Raises Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ameliora Wealth Management Ltd. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 400.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 520 shares of the company’s stock after buying an additional 416 shares during the quarter. Ameliora Wealth Management Ltd.’s holdings in GE HealthCare Technologies were worth $41,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in GEHC. LGT Financial Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC lifted its stake in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on GEHC. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $88.55 on Friday. The stock has a market capitalization of $40.46 billion, a price-to-earnings ratio of 24.33, a PEG ratio of 2.92 and a beta of 1.14. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a 50-day moving average of $83.25 and a 200 day moving average of $85.17.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a $0.035 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.